Elicio Therapeutics (ELTX) Q4 2025 Earnings

13NovConfirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-1.39
-1.09
-0.78
-0.48

Details

Expected EPS
-0.48
Actual EPS
-0.6
Surprise EPS
-0.12
Surprise Percent
+25%

Description

Elicio Therapeutics (ELTX) has reported earnings of -0.6 per share for Q4 2025.

0 Comments

Share your thoughts